Loading candles…
Indegene Ltd, incorporated in 1998, operates globally providing services to the life sciences, healthcare, biopharmaceutical, biotech, and medical devices industries. The company offers a range of solutions across several business segments, including analytics, technology, commercial services, medical services, regulatory services, safety services, and digitally-led commercialization services. Its products and services encompass analytics and technology solutions, commercial and medical services, regulatory affairs, pharmacovigilance, sales and marketing services, and clinical trials support. Indegene delivers these services by integrating healthcare domain expertise with technology, leveraging proprietary platforms and a workforce with strong clinical and medical backgrounds to provide outcomes-based solutions across clinical trials, regulatory affairs, medical affairs, pharmacovigilance, and sales and marketing within the global life sciences sector.
| Date |
|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 Apr 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 29 Jan 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025, and to recommend final dividend. | 28 Apr 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.